FDA Approves Genentech's Avastin As Treatment For Advanced Cervical Cancer

The U.S. Food and Drug Administration has approved Avastin for treating persistent, recurrent or late-stage cervical cancer. The drug interferes with blood vessels that fuel development of cancer cells.